Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Wrong-Way Crash on 210 Freeway Near Huntington Drive


2 Cars Collide Head-on in Fatal Monrovia Accident

Fatal Accident 6

Monrovia, CA (February 16, 2020) – One person was killed in a wrong-way crash in Monrovia. The fatal accident occurred on the morning of February 16 on the 210 Freeway.

A Chevrolet Cruze was traveling east in the westbound carpool lanes of the 210 Freeway, near Huntington Drive, when it crashed head-on with a sedan. One of the vehicles overturned. The wrong-way driver died in the crash. The driver of the sedan suffered major injuries and was taken to a local hospital. Roads were closed for several hours. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Monrovia

#91016


May 1, 2020

1 Killed, 2 Injured in Crash on 405 Freeway Near Beach Boulevard

Car Hits Caltrans Workers in Fatal Huntington Beach Accident...


May 19, 2020

1 Killed in Crash on Bee Canyon Truck Trail

Vehicle Crashes in Remote Area of Hemet...


December 3, 2019

2 Police Officers Injured in Crash at Magnolia Boulevard and Tujunga Avenue

Patrol Vehicle Hit by DUI Driver in Los Angeles Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.